**Core Concept**
Neostigmine is a cholinesterase inhibitor used to increase acetylcholine levels in the synaptic cleft, thereby enhancing cholinergic transmission. It is commonly used to reverse non-depolarizing muscle relaxants and treat myasthenia gravis.

**Why the Correct Answer is Right**
Neostigmine works by competitively inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine. This leads to an accumulation of acetylcholine in the synaptic cleft, increasing the frequency of acetylcholine receptor activation and enhancing cholinergic transmission. Neostigmine's effect is most pronounced in the neuromuscular junction, where it can reverse non-depolarizing muscle relaxants and improve muscle strength in patients with myasthenia gravis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because neostigmine does not act as a direct agonist at muscarinic or nicotinic receptors.
**Option B:** This option is incorrect because neostigmine is not a direct inhibitor of acetylcholine release from the presynaptic neuron.
**Option C:** This option is incorrect because neostigmine does not significantly affect the activity of butyrylcholinesterase, another enzyme involved in the breakdown of acetylcholine.

**Clinical Pearl / High-Yield Fact**
When using neostigmine to reverse non-depolarizing muscle relaxants, it is essential to administer it in conjunction with atropine or glycopyrrolate to prevent muscarinic side effects such as bradycardia and salivation.

**Correct Answer:** A.